| Summary: | A report on the State of Connecticut's lawsuit alleging major competitors in the generic pharmaceutical drug industry are engaged in a broad conspiracy to overcharge consumers. Connecticut Attorney General William Tong chronicles the way that multiple generic drug manufacturers systemically raised prices and divided up customers and markets to ensure maximum profit, a practice which is outlawed in the United States. Includes interviews with Connecticut Attorney General William Tong; Michael Cole, head of the antitrust division in the Connecticut Attorney General's office; prosecutor Joe Nielsen; and Dr. Thomas Pliura, who runs a clinic serving rural southern Illinois
|
|---|